PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

David Goldstein Chief NINDS to Speak At Neuropsychiatry Conference, September 22-23 in San Francisco - David S. Goldstein, M.D. Ph.D., Senior Investigator and Chief of Clinical Neurocardiology at NINDS, NIH to give a keynote presentation at GTC’s Advances in Neuropsychiatric Treatment Conference on Sept 22-23 in San Francisco, CA - GTCbio.com
David Goldstein Chief NINDS to Speak At Neuropsychiatry Conference, September 22-23 in San Francisco

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2011/06/08 - David S. Goldstein, M.D. Ph.D., Senior Investigator and Chief of Clinical Neurocardiology at NINDS, NIH to give a keynote presentation at GTC’s Advances in Neuropsychiatric Treatment Conference on Sept 22-23 in San Francisco, CA - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

David S. Goldstein, M.D. Ph.D., Senior Investigator and Chief of Clinical Neurocardiology at NINDS, NIH to give a keynote presentation titled “Willie Sutton’s Getaway Car and the Pathogenesis of Lewy Body Diseases” at GTC’s Advances in Neuropsychiatric Treatment Conference on Sept 22-23, 2011 in San Francisco, CA

Dr. Goldstein has been at NIH since 1978, tenured in 1984 (NHLBI), and founded and still leads the Clinical Neurocardiology Section in intramural NINDS in 1999. His discoveries include cardiac sympathetic denervation in Parkinson disease, stressor-specific activation of the sympathetic noradrenergic and adrenomedullary hormonal systems, sympathoadrenal imbalance preceding neurocardiogenic syncope, autoimmune autonomic ganglionopathy, and decreased vesicular uptake of neuronal catecholamines in Lewy body diseases. His current research focuses on biomarkers and mechanisms of loss of catecholaminergic neurons in Parkinson disease and related disorders.

Dr. Goldstein will present a conceptual framework for answering four key questions about the pathogenesis of Lewy body diseases. (1) Only a very small percent of neurons are catecholaminergic. What renders them susceptible? (2) All genotypic abnormalities identified so far that cause familial PD have no obvious relationship to catecholamines. How do generalized genetic predispositions lead to relatively specific loss of catecholaminergic neurons? (3) The protein alpha-synuclein is expressed in all neurons, and precipitated alpha-synuclein is a prominent component of Lewy bodies. Why does alpha-synuclein tend to precipitate in the cytosol of catecholaminergic neurons? And (4) Why are PD and DLB diseases of the elderly? The analogy of Willie Sutton’s getaway car provides a basis for new ideas about potential diagnostic, treatment, and preventative strategies in Lewy body diseases.

Other topics to be discussed at the conference include Neuroimaging Techniques for Drug Discovery, Neuropsychiatric Therapeutics, Cognition across Neuropsychiatric Disorders, New Treatments Hiding in Glutamate Synapses, The Role of Epigenetics and Genomics, and Lessons & Success in Clinical Trials.

Also presenting at the Advances in Neuropsychiatric Treatment Conference are prestigious organizations including Abbott, Addex Pharma, Amgen, Johnson & Johnson, National Psychosis Service (UK), Neuronetics, NIDA, NIH, Roche, Stanford, UC San Francisco, University of Michigan, UNC School of Medicine, Weill Cornell Med and other leaders in the neuroscience and psychiatry fields. For more information, please visit gtcbio.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


David Goldstein Chief NINDS to Speak At Neuropsychiatry Conference, September 22-23 in San Francisco

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  1Click Games

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)